General information about company | |
| Scrip code | 000000 |
| NSE Symbol | |
| MSEI Symbol | KRALEASING |
| ISIN* | INE300F01023 |
| Name of company | KRA LEASING LIMITED |
| Type of company | |
| Class of security | Equity |
| Date of start of financial year | 01-04-2023 |
| Date of end of financial year | 31-03-2024 |
| Date of board meeting when results were approved | 30-05-2024 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 23-05-2024 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Quarter | Yearly |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited | Audited |
| Segment Reporting | Single segment |
| Description of single segment | NBFC ACTIVITIES |
| Start date and time of board meeting | 30-05-2024 01:00 |
| End date and time of board meeting | 30-05-2024 02:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results – Ind-AS | |||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-01-2024 | 01-04-2023 |
| B | Date of end of reporting period | 31-03-2024 | 31-03-2024 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 189.67 | 444.27 | |
| Other income | -71.7 | 103.44 | |
| Total income | 117.97 | 547.71 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | 0 |
| (b) | Purchases of stock-in-trade | 0 | 0 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | 0 |
| (d) | Employee benefit expense | 0.54 | 2.16 |
| (e) | Finance costs | 0.44 | 4.5 |
| (f) | Depreciation, depletion and amortisation expense | 1.32 | 5.29 |
| (f) | Other Expenses | ||
| 1 | IMPAITMENT OF FINANCIAL INSTRUMENT | -25 | -75 |
| 2 | Other Expenses | 19.24 | 67.04 |
| 10 | |||
| Total other expenses | -5.76 | -7.96 | |
| Total expenses | -3.46 | 3.99 | |
Financial Results – Ind-AS | |||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-01-2024 | 01-04-2023 |
| B | Date of end of reporting period | 31-03-2024 | 31-03-2024 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 3 | Total profit before exceptional items and tax | 121.43 | 543.72 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Total profit before tax | 121.43 | 543.72 |
| 7 | Tax expense | ||
| 8 | Current tax | 23.44 | 112.8 |
| 9 | Deferred tax | 0.05 | -3.35 |
| 10 | Total tax expenses | 23.49 | 109.45 |
| 11 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 14 | Net Profit Loss for the period from continuing operations | 97.94 | 434.27 |
| 15 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 16 | Tax expense of discontinued operations | 0 | 0 |
| 17 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 19 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 21 | Total profit (loss) for period | 97.94 | 434.27 |
Financial Results – Ind-AS | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-01-2024 | 01-04-2023 |
| B | Date of end of reporting period | 31-03-2024 | 31-03-2024 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| Total Amount of items that will not be reclassified to profit and loss | |||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | ||
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | items that will be reclassified to profit or loss | 0 | -115.72 |
| Total Amount of items that will be reclassified to profit and loss | 0 | -115.72 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0 | -29.13 |
| 5 | Total Other comprehensive income | 0 | -86.59 |
Financial Results – Ind-AS | |||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-01-2024 | 01-04-2023 |
| B | Date of end of reporting period | 31-03-2024 | 31-03-2024 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 23 | Total Comprehensive Income for the period | 97.94 | 347.68 |
| 24 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 25 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 0 | 0 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | 0 | |
| 26 | Details of equity share capital | ||
| Paid-up equity share capital | 670.72 | 670.72 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 28 | Reserves excluding revaluation reserve | 0 | |
| 29 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.73 | 2.59 | |
| Diluted earnings (loss) per share from continuing operations | 0.73 | 2.59 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.73 | 2.59 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.73 | 2.59 | |
| 30 | Debt equity ratio | 0 | 0 |
| 31 | Debt service coverage ratio | 0 | 0 |
| 32 | Interest service coverage ratio | 0 | 0 |
| 33 | Disclosure of notes on financial results | ||
Statement of Asset and Liabilities | |||
| Particulars | Current year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-04-2023 | ||
| Date of end of reporting period | 31-03-2024 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 0 | ||
| Capital work-in-progress | 0 | ||
| Investment property | 229.13 | ||
| Goodwill | 0 | ||
| Other intangible assets | 0.4 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 0 | ||
| Non-current financial assets | |||
| Non-current investments | 509.55 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 0 | ||
| Other non-current financial assets | 0 | ||
| Total non-current financial assets | 509.55 | ||
| Deferred tax assets (net) | 0 | ||
| Other non-current assets | 0 | ||
| Total non-current assets | 739.08 | ||
| 2 | Current assets | ||
| Inventories | 0 | ||
| Current financial asset | |||
| Current investments | 0 | ||
| Trade receivables, current | 171.4 | ||
| Cash and cash equivalents | 115.62 | ||
| Bank balance other than cash and cash equivalents | 0.9 | ||
| Loans, current | 3773.02 | ||
| Other current financial assets | 8.85 | ||
| Total current financial assets | 4069.79 | ||
| Current tax assets (net) | 1.16 | ||
| Other current assets | 0.16 | ||
| Total current assets | 4071.11 | ||
Statement of Asset and Liabilities | |||
| Particulars | Current year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-04-2023 | ||
| Date of end of reporting period | 31-03-2024 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Standalone | ||
| 3 | Non-current assets classified as held for sale | ||
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | ||
| Total assets | 4810.19 | ||
| Equity and liabilities | |||
| Equity | |||
| Equity attributable to owners of parent | |||
| Equity share capital | 670.72 | ||
| Other equity | 4089.69 | ||
| Total equity attributable to owners of parent | 4760.41 | ||
| Non controlling interest | |||
| Total equity | 4760.41 | ||
| Liabilities | |||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 0 | ||
| Trade payables, non-current | 0 | ||
| Other non-current financial liabilities | 0 | ||
| Total non-current financial liabilities | 0 | ||
| Provisions, non-current | 0 | ||
| Deferred tax liabilities (net) | 0.05 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 0 | ||
| Total non-current liabilities | 0.05 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 0 | ||
| Trade payables, current | 0.54 | ||
| Other current financial liabilities | 30.54 | ||
| Total current financial liabilities | 31.08 | ||
| Other current liabilities | 7.46 | ||
| Provisions, current | 9.86 | ||
| Current tax liabilities (Net) | 1.33 | ||
| Deferred government grants, Current | |||
| Total current liabilities | 49.73 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
| 4 | Regulatory deferral account credit balances and related deferred tax liability | ||
| Total liabilities | 49.78 | ||
| Total equity and liabilites | 4810.19 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| Date of start of reporting period | 01-01-2024 | 01-04-2023 | |
| Date of end of reporting period | 31-03-2024 | 31-03-2024 | |
| Whether accounts are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| 1 | Segment Revenue (Income) | ||
| (net sale/income from each segment should be disclosed) | |||
| Total Segment Revenue | |||
| Less: Inter segment revenue | |||
| Revenue from operations | |||
| 2 | Segment Result | ||
| Profit (+) / Loss (-) before tax and interest from each segment | |||
| Total Profit before tax | |||
| i. Finance cost | |||
| ii. Other Unallocable Expenditure net off Unallocable income | |||
| Profit before tax | |||
| 3 | (Segment Asset - Segment Liabilities) | ||
| Segment Asset | |||
| Total Segment Asset | |||
| Un-allocable Assets | |||
| Net Segment Asset | |||
| 4 | Segment Liabilities | ||
| Segment Liabilities | |||
| Total Segment Liabilities | |||
| Un-allocable Liabilities | |||
| Net Segment Liabilities | |||
| Disclosure of notes on segments | |||
Cash flow statement, indirect | |||
| Particulars | Year ended (dd-mm-yyyy) | ||
| A | Date of start of reporting period | 01-01-2024 | |
| B | Date of end of reporting period | 31-03-2024 | |
| C | Whether results are audited or unaudited | Audited | |
| D | Nature of report standalone or consolidated | Standalone | |
| Part I | Blue color marked fields are non-mandatory. | ||
| Statement of cash flows [Abstract] | |||
| Cash flows from used in operating activities [Abstract] | |||
| Profit before tax | 543.72 | ||
| Adjustments for reconcile profit (loss) [Abstract] | |||
| Adjustments for finance costs | 4.5 | ||
| Adjustments for decrease (increase) in inventories | 0 | ||
| Adjustments for decrease (increase) in trade receivables, current | -117.06 | ||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | ||
| Adjustments for decrease (increase) in other current assets | -2369.95 | ||
| Adjustments for decrease (increase) in other non-current assets | 0 | ||
| Adjustments for other financial assets, non-current | 0 | ||
| Adjustments for other financial assets, current | 0 | ||
| Adjustments for other bank balances | 0 | ||
| Adjustments for increase (decrease) in trade payables, current | -4.56 | ||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | ||
| Adjustments for increase (decrease) in other current liabilities | -43.26 | ||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | ||
| Adjustments for depreciation and amortisation expense | 5.29 | ||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | ||
| Adjustments for provisions, current | 0 | ||
| Adjustments for provisions, non-current | 0 | ||
| Adjustments for other financial liabilities, current | 0 | ||
| Adjustments for other financial liabilities, non-current | 0 | ||
| Adjustments for unrealised foreign exchange losses gains | 0 | ||
| Adjustments for dividend income | 0 | ||
| Adjustments for interest income | 0 | ||
| Adjustments for share-based payments | 0 | ||
| Adjustments for fair value losses (gains) | -103.44 | ||
| Adjustments for undistributed profits of associates | 0 | ||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | ||
| Other adjustments to reconcile profit (loss) | 0 | ||
| Other adjustments for non-cash items | 0 | ||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | ||
| Total adjustments for reconcile profit (loss) | -2628.48 | ||
| Net cash flows from (used in) operations | -2084.76 | ||
| Dividends received | 0 | ||
| Interest paid | 0 | ||
| Interest received | 0 | ||
| Income taxes paid (refund) | 106.39 | ||
| Other inflows (outflows) of cash | 6.23 | ||
| Net cash flows from (used in) operating activities | -2184.92 | ||
| Cash flows from used in investing activities [Abstract] | |||
| Cash flows from losing control of subsidiaries or other businesses | 0 | ||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | ||
| Other cash receipts from sales of equity or debt instruments of other entities | 2075.5 | ||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | ||
| Other cash receipts from sales of interests in joint ventures | 0 | ||
| Other cash payments to acquire interests in joint ventures | 0 | ||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | ||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | ||
| Proceeds from sales of property, plant and equipment | 0 | ||
| Purchase of property, plant and equipment | 0 | ||
| Proceeds from sales of investment property | 0 | ||
| Purchase of investment property | 0 | ||
| Proceeds from sales of intangible assets | 0 | ||
| Purchase of intangible assets | 0 | ||
| Proceeds from sales of intangible assets under development | 0 | ||
| Purchase of intangible assets under development | 0 | ||
| Proceeds from sales of goodwill | 0 | ||
| Purchase of goodwill | 0 | ||
| Proceeds from biological assets other than bearer plants | 0 | ||
| Purchase of biological assets other than bearer plants | 0 | ||
| Proceeds from government grants | 0 | ||
| Proceeds from sales of other long-term assets | 0 | ||
| Purchase of other long-term assets | 0 | ||
| Cash advances and loans made to other parties | 0 | ||
| Cash receipts from repayment of advances and loans made to other parties | 0 | ||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Dividends received | 0 | ||
| Interest received | 0 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | 0 | ||
| Net cash flows from (used in) investing activities | 2075.5 | ||
| Cash flows from used in financing activities [Abstract] | |||
| Proceeds from changes in ownership interests in subsidiaries | 0 | ||
| Payments from changes in ownership interests in subsidiaries | 0 | ||
| Proceeds from issuing shares | 0 | ||
| Proceeds from issuing other equity instruments | 0 | ||
| Payments to acquire or redeem entity's shares | 0 | ||
| Payments of other equity instruments | 0 | ||
| Proceeds from exercise of stock options | 0 | ||
| Proceeds from issuing debentures notes bonds etc | 0 | ||
| Proceeds from borrowings | 0 | ||
| Repayments of borrowings | 0 | ||
| Payments of finance lease liabilities | 0 | ||
| Payments of lease liabilities | 0 | ||
| Dividends paid | 0 | ||
| Interest paid | 4.5 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | 0 | ||
| Net cash flows from (used in) financing activities | -4.5 | ||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -113.92 | ||
| Effect of exchange rate changes on cash and cash equivalents [Abstract] | |||
| Effect of exchange rate changes on cash and cash equivalents | 0 | ||
| Net increase (decrease) in cash and cash equivalents | -113.92 | ||
| Cash and cash equivalents cash flow statement at beginning of period | 229.54 | ||
| Cash and cash equivalents cash flow statement at end of period | 115.62 | ||